Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Bone Marrow Derived CD34 + CXCR4 + Cells Maintain Viability, Mobility and Sterility up to 72 Hours and Are Compatible with Balloon Dilatation Catheters Used for Intra Coronary Artery Infusion; Pre-Clinical Development of a Pharmaceutical Grade Cell Therapy for Acute Myocardial Infarction (AMR-001).

Andrew L. Pecora, MD, Robert A. Preti, PhD, Wai Shun Chan, PhD, Edmund K. Waller, M.D., PhD, Arshed Quyyumi, M.D., Douglas Vaughan, M.D., Thomas Moss, M.D.

Blood (2007) 110 (11): 1214.

https://doi.org/10.1182/blood.V110.11.1214.1214

Published: 2007

Journal Articles

Freezing and Cryostorage of Hematopoietic Progenitor Cells (HPC) Apheresis Using 5% Dimethyl Sulfoxide (DMSO) without Hydroxyethyl Starch (HES) in Cryocyte Freezing Bags and in Cryogenic Vials.

Wai Shun Chan, DPhil, Andrew L. Pecora, MD, Suzi Nadasi, Lester Myers, Margarita Munoz, Besa Jashari, Robert A. Preti, PhD

Blood (2006) 108 (11): 4184.

https://doi.org/10.1182/blood.V108.11.4184.4184

Published: 2006

Journal Articles

Comprehensive Immune Reconstitution without Development of Graft Versus Host Disease (GvHD) Using Limited T-Cell Add Back at the Time of Unrelated Multi-Antigen Mismatched Pan-T-Cell Depleted Transplant.

Thea M. Friedman, PhD, Jack W. Hsu, MD, Scott D. Rowley, MD, Stuart L. Goldberg, MD, Olga Azhipa, PhD, Jenny Zilberberg, PhD, Yevgeny Tkachuk, Robert A. Preti, PhD, Robert Korngold, PhD, Andrew L. Pecora, MD

Blood (2005) 106 (11): 5383.

https://doi.org/10.1182/blood.V106.11.5383.5383

Published: 2005

Journal Articles

A Myeloablative Conditioning Regimen Is Required to Produce Durable Engraftment and Immune Reconsitution in Related and Unrelated Multi-Antigen HLA Mismatched Pan-T-Cell Depleted Limited T-Cell Add-Back Transplants.

Jack W. Hsu, MD, Scott D. Rowley, MD, FACP, Stuart L. Goldberg, MD, David S. Siegel, MD, PhD, Robert A. Preti, PhD, Andrew L. Pecora, MD

Blood (2004) 104 (11): 5185.

https://doi.org/10.1182/blood.V104.11.5185.5185

Published: 2004

Journal Articles

Risk Adapted Dose Intensive DICEP Salvage Chemotherapy Prior to Autologous Stem Cell Transplantation Yields Successful Outcomes in Chemotherapy Refractory Lymphoma.

Stuart L. Goldberg, MD, Natalya Selina, MD, Manzurul A. Sikder, Jack W. Hsu, MD, David S. Siegel, MD, PhD, Andrew A. Jennis, MD, Richard J. Rosenbluth, MD, Robert A. Preti, PhD, Andrew L. Pecora, MD, Scott D. Rowley, MD

Blood (2004) 104 (11): 898.

https://doi.org/10.1182/blood.V104.11.898.898

Published: 2004

Journal Articles

Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab

Stuart L. Goldberg, Andrew L. Pecora, Robert S. Alter, Mark S. Kroll, Scott D. Rowley, Stanley E. Waintraub, Kavita Imrit, Robert A. Preti

Blood (2002) 99 (4): 1486–1488.

https://doi.org/10.1182/blood.V99.4.1486

Published: 2002

NARROW

Bone Marrow Derived CD34 + CXCR4 + Cells Maintain Viability, Mobility and Sterility up to 72 Hours and Are Compatible with Balloon Dilatation Catheters Used for Intra Coronary Artery Infusion; Pre-Clinical Development of a Pharmaceutical Grade Cell Therapy for Acute Myocardial Infarction (AMR-001).

Freezing and Cryostorage of Hematopoietic Progenitor Cells (HPC) Apheresis Using 5% Dimethyl Sulfoxide (DMSO) without Hydroxyethyl Starch (HES) in Cryocyte Freezing Bags and in Cryogenic Vials.

Comprehensive Immune Reconstitution without Development of Graft Versus Host Disease (GvHD) Using Limited T-Cell Add Back at the Time of Unrelated Multi-Antigen Mismatched Pan-T-Cell Depleted Transplant.

A Myeloablative Conditioning Regimen Is Required to Produce Durable Engraftment and Immune Reconsitution in Related and Unrelated Multi-Antigen HLA Mismatched Pan-T-Cell Depleted Limited T-Cell Add-Back Transplants.

Risk Adapted Dose Intensive DICEP Salvage Chemotherapy Prior to Autologous Stem Cell Transplantation Yields Successful Outcomes in Chemotherapy Refractory Lymphoma.

Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab

Email alerts

ASH Publications

American Society of Hematology

Bone Marrow Derived CD34 + CXCR4 + Cells Maintain Viability, Mobility and Sterility up to 72 Hours and Are Compatible with Balloon Dilatation Catheters Used for Intra Coronary Artery Infusion; Pre-Clinical Development of a Pharmaceutical Grade Cell Therapy for Acute Myocardial Infarction (AMR-001).

Freezing and Cryostorage of Hematopoietic Progenitor Cells (HPC) Apheresis Using 5% Dimethyl Sulfoxide (DMSO) without Hydroxyethyl Starch (HES) in Cryocyte Freezing Bags and in Cryogenic Vials.

Comprehensive Immune Reconstitution without Development of Graft Versus Host Disease (GvHD) Using Limited T-Cell Add Back at the Time of Unrelated Multi-Antigen Mismatched Pan-T-Cell Depleted Transplant.

A Myeloablative Conditioning Regimen Is Required to Produce Durable Engraftment and Immune Reconsitution in Related and Unrelated Multi-Antigen HLA Mismatched Pan-T-Cell Depleted Limited T-Cell Add-Back Transplants.

Risk Adapted Dose Intensive DICEP Salvage Chemotherapy Prior to Autologous Stem Cell Transplantation Yields Successful Outcomes in Chemotherapy Refractory Lymphoma.

Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only